Ocrevus
We provide customized and high-quality ocrelizumab product for your project.
Ocrelizumab is an anti-CD20 monoclonal antibody developed by Genentech to treat relapsing and primary progressive forms of multiple sclerosis (MS).
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View